Department of Atherosclerosis of SOCERGS
Indications of the use of PCSK9 Inhibitors in patients with High Risk and Very High Cardiovascular risk.
Authors:
Paulo Eduardo Ballvé Behr
São Lucas Hospital of PUCRS
Emilio Hideyuki Moriguchi
Faculty of Medicine, Federal University of Rio Grande do Sul; Department of Cardiology, Hospital of Clinics of Porto Alegre, Porto Alegre, Brazil.
Iran Castro
Institute of Cardiology
University Foundation of Cardiology
Luiz Carlos Bodanese
São Lucas Hospital of PUCRS
Oscar Pereira Dutra
Institute of Cardiology
University Foundation of Cardiology
Paulo Ernesto Leães
Santa Casa de Misericórdia Brotherhood of Porto Alegre
Pedro Pimentel Filho
Hospital Nossa Senhora da Conceição, Porto Alegre, RS, Brazil
Indications of the use of PCSK9 Inhibitors in patients with High Risk and Very High Cardiovascular risk.
Authors:
Paulo Eduardo Ballvé Behr
São Lucas Hospital of PUCRS
Emilio Hideyuki Moriguchi
Faculty of Medicine, Federal University of Rio Grande do Sul; Department of Cardiology, Hospital of Clinics of Porto Alegre, Porto Alegre, Brazil.
Iran Castro
Institute of Cardiology
University Foundation of Cardiology
Luiz Carlos Bodanese
São Lucas Hospital of PUCRS
Oscar Pereira Dutra
Institute of Cardiology
University Foundation of Cardiology
Paulo Ernesto Leães
Santa Casa de Misericórdia Brotherhood of Porto Alegre
Pedro Pimentel Filho
Hospital Nossa Senhora da Conceição, Porto Alegre, RS, Brazil
Show More